GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Optimi Health Corp (XCNQ:OPTI) » Definitions » LT-Debt-to-Total-Asset

Optimi Health (XCNQ:OPTI) LT-Debt-to-Total-Asset : 0.17 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Optimi Health LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Optimi Health's long-term debt to total assests ratio for the quarter that ended in Mar. 2024 was 0.17.

Optimi Health's long-term debt to total assets ratio increased from Mar. 2023 (0.00) to Mar. 2024 (0.17). It may suggest that Optimi Health is progressively becoming more dependent on debt to grow their business.


Optimi Health LT-Debt-to-Total-Asset Historical Data

The historical data trend for Optimi Health's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Optimi Health LT-Debt-to-Total-Asset Chart

Optimi Health Annual Data
Trend Sep20 Sep21 Sep22 Sep23
LT-Debt-to-Total-Asset
0.02 0.01 - 0.10

Optimi Health Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.10 0.17 0.17

Optimi Health LT-Debt-to-Total-Asset Calculation

Optimi Health's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Sep. 2023 is calculated as

LT Debt to Total Assets (A: Sep. 2023 )=Long-Term Debt & Capital Lease Obligation (A: Sep. 2023 )/Total Assets (A: Sep. 2023 )
=1.671/16.492
=0.10

Optimi Health's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2024 is calculated as

LT Debt to Total Assets (Q: Mar. 2024 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2024 )/Total Assets (Q: Mar. 2024 )
=2.624/15.193
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Optimi Health  (XCNQ:OPTI) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Optimi Health LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Optimi Health's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Optimi Health Business Description

Traded in Other Exchanges
Address
21 Water Street, Suite 600, Vancouver, BC, CAN, V6B 1A1
Optimi Health Corp operates in developing a vertically integrated Canadian functional mushroom brand that focuses on the health and wellness sector. The company has one reportable operating segment being that of the farming, processing, and distribution of raw mushroom biomass. It also intends to cultivate, extract, process, and distribute strains of fungi products at its facilities located in Princeton, British Columbia.
Executives
Dane Nicholas Stevens Director, Senior Officer
Bryan Edward Safarik Director, Senior Officer
William John Ciprick Senior Officer
Jacob Frederick Safarik Director, Senior Officer
Jonathan Schintler Director
John James Wilson Director
Michael Alan Stier Director